Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
05/08/201612:00GlobeNewswire Inc.Summit Therapeutics to Present at Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
18/07/201621:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
24/06/201621:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
20/06/201617:30GlobeNewswire Inc.Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
17/06/201621:23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
17/06/201612:00GlobeNewswire Inc.First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMDNASDAQ:SMMTSummit Therapeutics Inc
16/06/201612:00GlobeNewswire Inc.Summit Therapeutics to Present at JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
08/06/201612:00GlobeNewswire Inc.Summit Therapeutics to Host Utrophin R&D Day 15 June 2016NASDAQ:SMMTSummit Therapeutics Inc
06/06/201611:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
02/06/201621:36Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
02/06/201612:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2016 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
31/05/201612:00GlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2016 on 2 June 2016NASDAQ:SMMTSummit Therapeutics Inc
26/05/201621:17Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:SMMTSummit Therapeutics Inc
25/05/201614:44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
23/05/201612:00GlobeNewswire Inc.Summit to Present Phase 2 CoDIFy Trial Data Highlighting Ridinilazole's Preservation of the Microbiome in CDI Patients at ASM...NASDAQ:SMMTSummit Therapeutics Inc
12/05/201611:06Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
12/05/201611:06Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
10/05/201622:55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
10/05/201612:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2016NASDAQ:SMMTSummit Therapeutics Inc
06/05/201612:00GlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2016NASDAQ:SMMTSummit Therapeutics Inc
29/04/201612:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
28/04/201616:46GlobeNewswire Inc.Summit’s IND Cleared by FDA Allowing Expansion of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid (SMT C1100), Into the...NASDAQ:SMMTSummit Therapeutics Inc
28/04/201612:00GlobeNewswire Inc.Summit Announces Further US Patent Granted for CDI Antibiotic RidinilazoleNASDAQ:SMMTSummit Therapeutics Inc
26/04/201621:33Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
12/04/201622:12Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/04/201612:00GlobeNewswire Inc.Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infe...NASDAQ:SMMTSummit Therapeutics Inc
06/04/201612:00GlobeNewswire Inc.Summit Therapeutics to Present at 15th Annual Needham Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
30/03/201621:54Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
30/03/201612:00GlobeNewswire Inc.Summit Reports Positive Interim Data From Ongoing Phase 1 Clinical Trial Testing a New Formulation of SMT C1100 in Patients W...NASDAQ:SMMTSummit Therapeutics Inc
29/03/201614:25GlobeNewswire Inc.Summit to Present Additional Data From Phase 2 CoDIFy Trial Showing Ridinilazole’s Statistical Superiority Over Vancomycin ...NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

Delayed Upgrade Clock